These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28657348)

  • 1. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China.
    Wen L; Wu J; Feng L; Yang L; Qian F
    Curr Med Res Opin; 2017 Oct; 33(10):1789-1794. PubMed ID: 28657348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of atrial fibrillation on stroke-related healthcare costs.
    Sussman M; Menzin J; Lin I; Kwong WJ; Munsell M; Friedman M; Selim M
    J Am Heart Assoc; 2013 Nov; 2(6):e000479. PubMed ID: 24275631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
    J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier: A 15-Year Nationwide Study.
    Santos JV; Pereira J; Pinto R; Castro PM; Azevedo E; Freitas A
    Value Health; 2017 Sep; 20(8):1083-1091. PubMed ID: 28964440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
    Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
    Amin AN; Jhaveri M; Lin J
    Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA.
    Deitelzweig SB; Lovelace B; Christoph M; Lingohr-Smith M; Lin J; Fermann GJ
    Adv Ther; 2020 Sep; 37(9):3942-3953. PubMed ID: 32699994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors.
    Deitelzweig S; Neuman WR; Lingohr-Smith M; Menges B; Lin J
    J Med Econ; 2017 Dec; 20(12):1217-1223. PubMed ID: 28760063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention
.
    Masbah N; Macleod MJ
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
    Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.
    Li X; Tse VC; Au-Doung LW; Wong ICK; Chan EW
    Europace; 2017 Jun; 19(6):937-947. PubMed ID: 27209573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China.
    Zhang H; Yin Y; Zhang C; Zhang D
    BMC Health Serv Res; 2019 Sep; 19(1):671. PubMed ID: 31533714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany.
    McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B
    Value Health; 2009; 12(2):293-301. PubMed ID: 18657103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm.
    Ali AN; Howe J; Abdel-Hafiz A
    Pharmacoeconomics; 2015 May; 33(5):511-20. PubMed ID: 25693879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.
    Laliberté F; Cloutier M; Crivera C; Nelson WW; Olson WH; Schein J; Vanderpoel J; Germain G; Lefebvre P
    Clin Ther; 2015 Mar; 37(3):554-62. PubMed ID: 25749196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.
    Laliberté F; Cloutier M; Crivera C; Nelson WW; Olson WH; Schein J; Vanderpoel J; Germain G; Lefebvre P
    Adv Ther; 2015 Mar; 32(3):216-27. PubMed ID: 25784509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001.
    Ghatnekar O; Glader EL
    Value Health; 2008; 11(5):862-8. PubMed ID: 18489491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?
    Laliberté F; Pilon D; Raut MK; Nelson WW; Olson WH; Germain G; Schein JR; Lefebvre P
    Curr Med Res Opin; 2014 Aug; 30(8):1521-8. PubMed ID: 24758611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.
    Cotté FE; Chaize G; Gaudin AF; Samson A; Vainchtock A; Fauchier L
    Europace; 2016 Apr; 18(4):501-7. PubMed ID: 26718532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.